MFDS active in supping development of Alzheimer-type dementia treatments
While the pharmaceutical industry has been active in developing combination drugs improved in safety and effectiveness, the Ministry of Food and Drug Safety(MFDS) will support pharmaceutical companies for development of combination medicines for the treatment of dementia.
According to the MFDS, ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.